ValiRx PLC (VAL)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.40p

Buy

0.44p

arrow-up0.095p (+29.23%)

Prices updated at 17 Dec 2025, 16:40 GMT

Prices minimum 15 mins delay

Prices in GBX

ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.

FTSE All-Share

0.88%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	0.45p - 0.31p
	0.95p - 0.22p
	-
	2.41m
	-
	500,000
	41,632,390
	0.70
	6,858,120.53
	-2.77
	374.35m
	GB00BLH13C52
	-0.01
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.